In vitro effects of polyphenols on colorectal cancer cells

被引:23
作者
Pampaloni, Barbara [1 ]
Palmini, Gaia [1 ]
Mavilia, Carmelo [1 ]
Zonefrati, Roberto [1 ]
Tanini, Annalisa [1 ]
Brandi, Maria Luisa [1 ]
机构
[1] Univ Florence, Dept Surg & Translat Med, Largo Palagi 1, I-50139 Florence, Italy
关键词
Estrogen receptor; HCT8-beta; 8; cells; HCT8-SV2neo; Quercetin; Genistein;
D O I
10.4251/wjgo.v6.i8.289
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM: To investigate the effects of quercetin and genistein on colon cancer cell proliferation and their estrogen receptor beta( ER beta) expression. METHODS: Colon cancer cells were stably transfected with a mammalian expression vector to overexpress ER beta ( HCT8-beta 8-expressing cells) or a control vector ( HCT8-pSV2neo-expressing cells). The proliferation of these cells was examined after treatment with quercetin or genistein (5-100 mu mol/L), or 10 nmol/L 17 beta-estradiol (17 beta-E2). Cell viability was examined by acridine orange staining following treatments for 48 or 144 h. Effects of quercetin and genistein on ER beta transcriptional transactivation were examined by luciferase activity in HCT8-beta 8-expressing cells transiently transfected with a pEREtkLUC reporter vector. In addition, the regulation of ER beta transcription by phytoestrogens and 17 beta-E2 was examined by quantitative polymerase chain reaction. RESULTS: Proliferation of HCT8-beta 8-expressing cells was not reduced low doses (5 mu mol/L) of quercetin and genistein, while it was reduced at 25-50 mu mol/L with an effect similar to 10 nmol/L 17 beta-E2. Treatment with doses of phytoestrogens >= 75 mu mol/L completely blocked cell growth and reduced overall cell counts, however no effects at any dose were observed in HCT8-pSV2neoexpressing cells. These results were supported by viability staining that revealed acridine orange-stained lysosomes with high doses or extended treatment periods. Genistein and quercetin (50 mu mol/L) significantly increased ER-responsive luciferase activity similar to 10 nmol/L 17 beta-E2 (P < 0.05). Furthermore, genistein and quercetin (50 mu mol/L), as well as 10 nmol/L 17 beta-E2 significantly increased ER beta mRNA levels in HCT8-beta 8expressing cells (P < 0.05). In addition, treatment of HCT8-pSV2neo-expressing cells with 50 mu mol/L quercetin or 10 nmol/L 17 beta-E2 significantly increased ER beta mRNA levels compared to untreated controls (P < 0.05), though the absolute levels were much lower than in HCT8-beta 8-expressing cells. CONCLUSION: The antitumorigenic effects of the phytoestrogenic compounds quercetin and genistein on colon cancers cells occur through ER beta activity and expression. (C) 2014 Baishideng Publishing Group Inc. All rights reserved.
引用
收藏
页码:289 / 300
页数:12
相关论文
共 61 条
[51]   Soy consumption and colorectal cancer [J].
Spector, D ;
Anthony, M ;
Alexander, D ;
Arab, L .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 2003, 47 (01) :1-12
[52]   Estrogen receptor β inhibits 17β-estradiol-stimulated proliferation of the breast cancer cell line T47D [J].
Ström, A ;
Hartman, J ;
Foster, JS ;
Kietz, S ;
Wimalasena, J ;
Gustafsson, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (06) :1566-1571
[53]   CULTURAL AND ANTIGENIC PROPERTIES OF NEWLY ESTABLISHED CELL STRAINS DERIVED FROM ADENOCARCINOMAS OF HUMAN COLON AND RECTUM [J].
TOMPKINS, WA ;
WATRACH, AM ;
SCHMALE, JD ;
SCHULTZ, RM ;
HARRIS, JA .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 52 (04) :1101-1110
[54]   Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans [J].
van der Woude, H ;
Gliszczynska-Swiglo, A ;
Struijs, K ;
Smeets, A ;
Alink, GM ;
Rietjens, IMCM .
CANCER LETTERS, 2003, 200 (01) :41-47
[55]   Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro [J].
van Erk, MJ ;
Roepman, P ;
van der Lende, TR ;
Stierum, RH ;
Aarts, JMMJG ;
van Bladeren, PJ ;
van Ommen, B .
EUROPEAN JOURNAL OF NUTRITION, 2005, 44 (03) :143-156
[56]   Isoflavone intake in four different European countries: the VENUS approach [J].
van Erp-Baart, MAJ ;
Brants, HAM ;
Kiely, M ;
Mulligan, A ;
Turrini, A ;
Sermoneta, C ;
Kilkkinen, A ;
Valsta, LM .
BRITISH JOURNAL OF NUTRITION, 2003, 89 :S25-S30
[57]   Dietary intake and sources of isoflavones among Japanese [J].
Wakai, K ;
Egami, I ;
Kato, K ;
Kawamura, T ;
Tamakoshi, A ;
Lin, YS ;
Nakayama, T ;
Wada, M ;
Ohno, Y .
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL, 1999, 33 (02) :139-145
[58]   Cumulative Risk of Colon Cancer up to Age 70 Years by Risk Factor Status Using Data From the Nurses' Health Study [J].
Wei, Esther K. ;
Colditz, Graham A. ;
Giovannucci, Edward L. ;
Fuchs, Charles S. ;
Rosner, Bernard A. .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2009, 170 (07) :863-872
[59]   Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk [J].
Wong, Hui-Lee ;
Peters, Ulrike ;
Hayes, Richard B. ;
Huang, Wen-Yi ;
Schatzkin, Arthur ;
Bresalier, Robert S. ;
Velie, Ellen M. ;
Brody, Lawrence C. .
EUROPEAN JOURNAL OF CANCER, 2010, 46 (13) :2457-2466
[60]   Inhibition of proliferation and induction of apoptosis by genistein in colon cancer HT-29 cells [J].
Yu, ZL ;
Li, WJ ;
Liu, FY .
CANCER LETTERS, 2004, 215 (02) :159-166